Vraylar 3 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FP7XC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,643
Award facts
- Contract value 100% obligated
- $12,642.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Vraylar 3 mg capsules (30-count units) under a firm fixed-price contract valued at $12,642.90, with completion scheduled for December 10, 2025. The award was competitively procured with no set-aside designation. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that establishes a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Vraylar order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare entities through the flexible procurement framework established under the DLA Troop Support Medical prime vendor program, which anticipates multiple regional awards under the next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2DR26FP7XC?
SPE2DR26FP7XC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FP7XC worth?
The government has obligated $12,643 on SPE2DR26FP7XC.
Is contract SPE2DR26FP7XC an order under another contract?
Yes. SPE2DR26FP7XC is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP7XC competed?
The extent of competition for SPE2DR26FP7XC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award